05/21/2013
05/21/2013
Impressive Q1:13 Results and Q2:13 Guidance Suggests Recovery Around the Corner
05/21/2013
Q1:13 Results and PreSERVE Phase 2 Clinical Trial Update; Reiterate Buy
05/20/2013
05/20/2013
New products to provide new direction; Maintain Buy; $4 Price Target